H.R. 1796

Status: In committee

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

Sponsored by John James (Republican-MI-10)

Topics

Cosponsors

6

Actions

3

Roll calls

0

Amendments

0

Related bills

4

Actions

Mar 3, 2025 · Library of Congress

Introduced in House

Mar 3, 2025 · Library of Congress

Introduced in House

Mar 3, 2025 · House floor actions

Referred to the House Committee on Energy and Commerce.

Latest activity

July 2026

Lobbying reported · The Mcmanus Group · Jul 20

The Mcmanus Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Fulcrum Therapeutics — $60,000

BillsH.R. 1796 S. 735

Lobbying reported · Indigo Hill Strategies · Jul 20

Indigo Hill Strategies reported 2nd Quarter (Apr 1 - June 30) lobbying for Sick Cells — $30,000

BillsH.R. 1796 H.R. 5178 S. 735

Lobbying reported · Ogr · Jul 18

Ogr reported 2nd Quarter (Apr 1 - June 30) lobbying for Leavitt Partners, LLC On Behalf Of Sickle Cell Disease Partnership — $20,000

BillsH.R. 1796 H.R. 5178

You’re all caught up.